Browsing Laboratory of Epidemiology and Public Health by Author "C., Bektur"

Now showing items 1-1 of 1

PMS17 Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstan

Bektur, C.; Nurgozhin, T. (2014-11-01)

A phase III clinical trial demonstrated the advantage of denosumab over zoledronic acid(ZA) in delaying the first on-study and subsequent skeletal-related events(SREs) in patients with prostate cancer(PC). Recently, generic ...